LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $581,000 | -3.5% | 6,744 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $602,000 | -20.7% | 6,744 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $759,000 | -27.2% | 6,744 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,042,000 | -52.2% | 6,744 | -56.9% | 0.00% | -60.0% |
| Q3 2021 | $2,178,000 | +6.2% | 15,634 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $2,051,000 | -13.9% | 15,634 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $2,383,000 | +53.2% | 15,634 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $1,555,000 | -3.1% | 15,634 | -7.1% | 0.00% | 0.0% |
| Q3 2020 | $1,605,000 | -59.8% | 16,834 | -52.9% | 0.00% | -63.6% |
| Q2 2020 | $3,995,000 | +226.4% | 35,717 | +112.2% | 0.01% | +175.0% |
| Q1 2020 | $1,224,000 | -30.3% | 16,834 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $1,756,000 | – | 16,834 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |